US equities |
MU $951.91 ▼-3.75% META $762.61 ▲+2.64% NVDA $228.37 ▲+0.90% SNDK $1,480.81 ▼-0.44% AAPL $340.99 ▲+0.00% MSFT $543.19 ▲+0.38% SPCX $156.63 ▼-4.16% AMD $605.70 ▲+1.93%
FinancialContent

Assertio Holdings, Inc. - Common Stock (NQ:ASRT)

23.50 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Assertio Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Assertio Announces Completion of Merger with Zydus Lifesciences and Fundamental Change and Make-Whole Fundamental Change Relating to its Outstanding 6.50% Convertible Senior Notes due 2027
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Shareholder Alert: Ademi LLP investigates whether Assertio Holdings Inc. is obtaining a Fair Price for Public Shareholders
From Ademi LLP
Via GlobeNewswire
News headline image
Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Assertio to Be Acquired by Zydus Worldwide DMCC for $23.50 Per Share in Cash
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Assertio and Garda Mutually Agree to Delay Launch of Tender Offer
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Assertio and Garda Mutually Agree to Postpone Commencement of Tender Offer
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Assertio and Garda Mutually Agree to Extend Tender Offer Deadline
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Assertio Provides Update on Garda Therapeutics Tender Process
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Halper Sadeh LLC is Investigating Whether WSR, MKC, OMEX, ASRT are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether EHAB, WSR, SEM, ASRT are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
ASRT Stock Alert: Halper Sadeh LLC is Investigating Whether Assertio Holdings, Inc. is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
ASRT Stock Alert: Halper Sadeh LLC is Investigating Whether Assertio Holdings, Inc. is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Assertio Announces Agreement to be Acquired by Garda Therapeutics
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Assertio Reports Fourth Quarter and Full Year 2025 Financial Results
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Assertio Reports Third Quarter 2025 Financial Results
From Assertio Holdings, Inc.
Via Business Wire
News headline image
DEADLINE NEXT WEEK: Berger Montague Advises Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investors to Contact the Firm Before September 24, 2025
From Berger Montague
Via GlobeNewswire
News headline image
SHAREHOLDER ALERT: Berger Montague Reminds Spectrum Pharmaceuticals (NASDAQ: SPPI) Investors of Class Action Lawsuit Deadline
From Berger Montague
Via GlobeNewswire
News headline image
Notice of Pendency of Action on Behalf of Purchasers of Spectrum Pharmaceuticals, Inc. (SPPI) Common Stock and the Reopening of the Lead Plaintiff Process
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
News headline image
Notice of Pendency of Action on Behalf of Purchasers of Spectrum Pharmaceuticals, Inc. (SPPI) Common Stock and the Reopening of the Lead Plaintiff Process
Via TheNewswire.com
Topics Regulatory Compliance
News headline image
ATTENTION NASDAQ: SPPI INVESTORS: Contact Berger Montague About a Spectrum Pharmaceuticals Class Action Lawsuit
From Berger Montague
Via GlobeNewswire
News headline image
iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025
Via ACCESS Newswire
News headline image
INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Assertio Holdings, Inc. (NASDAQ: ASRT); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel
From DiCello Levitt LLP
Via GlobeNewswire
News headline image
Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer
From Beam Therapeutics
Via GlobeNewswire
News headline image
ASSERTIO ALERT: Bragar Eagel & Squire, P.C. is Investigating Assertio Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >